Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
752.00
554.00
555.00
611.00
453.00
511.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
43.00
32.00
35.00
48.00
41.00
46.00
Net Sales
709.00
522.00
519.00
563.00
411.00
464.00
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
36.00
-112.00
26.00
-13.00
-14.00
Raw Materials Consumed
425.00
299.00
387.00
313.00
259.00
307.00
Power & Fuel Cost
47.00
35.00
32.00
23.00
18.00
21.00
Employee Cost
64.00
53.00
51.00
41.00
39.00
35.00
Operating Expenses
26.00
17.00
22.00
16.00
14.00
13.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
4.00
3.00
3.00
5.00
3.00
2.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
2.00
2.00
2.00
2.00
2.00
1.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
592.00
467.00
405.00
442.00
332.00
374.00
Operating Profit (PBDIT) excl Other Income
116.00
54.00
114.00
121.00
79.00
90.00
Other Income
4.00
4.00
5.00
3.00
5.00
3.00
Operating Profit (PBDIT)
121.00
59.00
119.00
124.00
85.00
93.00
Interest
23.00
21.00
18.00
11.00
12.00
11.00
Profit before Depriciation and Tax
97.00
37.00
100.00
113.00
72.00
81.00
Depreciation
31.00
32.00
32.00
22.00
22.00
19.00
Profit Before Taxation & Exceptional Items
66.00
5.00
68.00
91.00
50.00
62.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
66.00
5.00
68.00
91.00
50.00
62.00
Provision for Tax
16.00
1.00
0.00
30.00
18.00
20.00
Profit After Tax
49.00
3.00
67.00
60.00
32.00
41.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
287.00
297.00
247.00
195.00
179.00
151.00
Profit Available for appropriations
337.00
290.00
309.00
257.00
210.00
191.00
Appropriations
337.00
290.00
309.00
257.00
210.00
191.00
Equity Dividend (%)
40.00%
30.00%
30.00%
30.00%
25.00%
25.00%
Earnings Per Share
5.89
-0.83
7.35
7.39
3.73
4.73
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 35.86% vs 0.42% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 114.08% vs -52.35% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 7.04% vs 16.09% in Mar 2023
Profit After Tax
YoY Growth in year ended Mar 2024 is 1,166.70% vs -94.28% in Mar 2023
Compare Profit and Loss Results of SMS Pharma.
Figures in Rs cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
752.00
10,334.00
-9,582.00
-92.72%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
43.00
0.00
43.00
0%
Net Sales
709.00
10,334.00
-9,625.00
-93.14%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-94.00
93.00
98.94%
Raw Materials Consumed
425.00
3,263.00
-2,838.00
-86.98%
Power & Fuel Cost
47.00
129.00
-82.00
-63.57%
Employee Cost
64.00
2,274.00
-2,210.00
-97.19%
Operating Expenses
26.00
210.00
-184.00
-87.62%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
928.00
-924.00
-99.57%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
134.00
-132.00
-98.51%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
592.00
7,798.00
-7,206.00
-92.41%
Operating Profit (PBDIT) excl Other Income
116.00
2,536.00
-2,420.00
-95.43%
Other Income
4.00
280.00
-276.00
-98.57%
Operating Profit (PBDIT)
121.00
2,817.00
-2,696.00
-95.70%
Interest
23.00
35.00
-12.00
-34.29%
Profit before Depriciation and Tax
97.00
2,782.00
-2,685.00
-96.51%
Depreciation
31.00
398.00
-367.00
-92.21%
Profit Before Taxation & Exceptional Items
66.00
2,384.00
-2,318.00
-97.23%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
66.00
2,399.00
-2,333.00
-97.25%
Provision for Tax
16.00
457.00
-441.00
-96.50%
Profit After Tax
49.00
1,926.00
-1,877.00
-97.46%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
287.00
8,012.00
-7,725.00
-96.42%
Profit Available for appropriations
337.00
9,925.00
-9,588.00
-96.60%
Appropriations
337.00
9,925.00
-9,588.00
-96.60%
Equity Dividend (%)
40%
0%
40.00
Earnings Per Share
5.89
47.75
-41.86
-87.66%
Profit And Loss - Net Sales
Net Sales 709.26 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 35.86% vs 0.42% in Mar 2023
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 116.62 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 114.08% vs -52.35% in Mar 2023
Profit And Loss - Interest
Interest 23.46 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 7.04% vs 16.09% in Mar 2023
Profit And Loss - Profit After Tax
Profit After Tax 49.20 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 1,166.70% vs -94.28% in Mar 2023